Fitch Upgrades BAT to 'A-' as Smokeless Growth and Buybacks Drive Modest 0.07% Rally Amid 277th Trading Rank

Market Snapshot

British American Tobacco (BTI) posted a modest gain of 0.07% on March 13, 2026, with a trading volume of $0.42 billion, ranking 277th in overall trading activity for the day. Despite the limited price movement, the stock’s performance aligns with broader market conditions, where moderate liquidity and investor caution appear to have tempered larger swings. The session’s data underscores the stock’s relatively low volatility, a characteristic often associated with established tobacco firms with stable cash flows.

Key Drivers Behind the Upgrade

Fitch Ratings’ recent upgrade of British American Tobacco’s long-term issuer default rating to ‘A-’ from ‘BBB+’ has emerged as a pivotal catalyst for investor sentiment. The ratings agency cited the company’s robust business profile, emphasizing its global scale, regional diversification, and consistent profitability. Fitch noted that BAT’s next-generation products—such as modern oral and heated tobacco alternatives—contributed £442 million in operating income in 2025, reflecting a nearly 80% year-over-year increase. This shift toward smokeless and vapor alternatives, which now account for 18% of net sales, positions BAT to mitigate regulatory risks and align with evolving consumer preferences.

The upgrade also highlights BAT’s strong free cash flow generation, with Fitch projecting £1.8 billion to £2.4 billion annually from 2026 to 2028. This is underpinned by low- to mid-single-digit organic revenue growth and an EBITDA margin expected to rise to 48% by 2028. The ratings agency attributed this improvement to cost efficiencies and the expansion of high-growth product categories. Additionally, BAT’s conservative financial policy—targeting a net leverage ratio of 2.0x to 2.5x—reinforces its creditworthiness. Fitch-adjusted EBITDA net leverage is projected to decline from 2.6x in 2025 to 2.3x by 2027, further supporting the upgraded rating.

Strategic capital allocation, including a £1.3 billion share buyback plan for 2026 and an anticipated £3.2 billion in repurchases over 2027–2028, underscores BAT’s commitment to shareholder returns. These initiatives, combined with its stable operating cash flows, reduce the risk of overleveraging while enhancing equity value. However, challenges persist in the traditional combustible segment, where BAT’s U.S. market volume declined by 7% to 8% in 2025, albeit at a slower rate than prior years. The company’s ability to offset combustible declines with smokeless growth remains critical to sustaining its credit profile.

While the U.S. vapor market—where BAT holds a 52% stake—faced a 13% volume drop in 2025 due to unenforced regulations against illicit products, the firm’s focus on modern oral products (up 48% in revenue) has softened the blow. Fitch acknowledged that BAT’s smokeless portfolio is less diversified than Philip Morris International’s 42% contribution but noted its potential to narrow this gap through innovation. The stable outlook reflects confidence in BAT’s ability to navigate regulatory headwinds while capitalizing on its first-mover advantage in next-gen products.

In summary, the credit upgrade by Fitch, coupled with BAT’s strategic pivot to smokeless alternatives and disciplined capital management, has provided a foundation for cautious optimism. The 0.07% price increase, though modest, reflects investor recognition of these structural strengths, even as macroeconomic and regulatory uncertainties linger in the tobacco sector.